speb/financial-data huggingface dataset:
Financial ratios for CARS — quarterly report dated 2025-09-30
Total revenue: 181573000
Gross profit: 151510000
Operating income: 16805000
Net income: 7658000
Capital expenditures: 559000
Operating cash flow: 58838000
Depreciation & amortization: 23464000
Net tangible assets: -226208000
Owner earnings: 30563000
Return on net tangible assets (%): -13.51101640967605
Capex to operating income (%): 3.326390955072895
Buffett classification: The Great
Stock price: 12.22
P/E ratio: 53.9856954275328
Shares outstanding: 55903027
Book value: 477569000
P/B ratio: 1.4304424909070732
Market cap (USD): 683134989.94
Debt to equity: 0.9447975057007469
Current ratio: 1.8177864902113525
Quick ratio: 1.8177864902113525
Effective tax rate (%): 28.44328162960194
Interest coverage ratio: 2.2022015463242037
COGS to revenue (%): 16.55697708359723
R&D to revenue (%): 15.18948301784957
SG&A to revenue (%): 46.075683058604525
Free cash flow (dilution-adjusted): 45222000
Buyback yield (%): 2.8830319468381815
Retained earnings: -948892000
Receivables turnover: 1.4094546865903357
Capitalized R&D asset: 56868390
ROCI (R&D-adjusted, %): 1.5266736975256874
Rosenberg metric: 0.11587623105399175
FCF margin (%): 24.9056853166495
Revenue growth (%): 1.5855521178925696
Rule of 40 score: 26.491237434542068
Financial ratios for CARS — annual report dated 2025-12-31
Total revenue: 723239000
Gross profit: 599911000
Operating income: 60250000
Net income: 20052000
Capital expenditures: 4286000
Operating cash flow: 151639000
Depreciation & amortization: 91842000
Net tangible assets: -221759000
Owner earnings: 107608000
Return on net tangible assets (%): -48.52474984104366
Capex to operating income (%): 7.113692946058091
Buffett classification: The Great
Stock price: 12.2
P/E ratio: 34.012414193097946
Shares outstanding: 55903027
Book value: 472530000
P/B ratio: 1.4433304327767549
Market cap (USD): 682016929.4
Debt to equity: 0.9555287494973864
Current ratio: 1.8661045798901108
Quick ratio: 1.8661045798901108
Effective tax rate (%): 41.549583163295054
Interest coverage ratio: 1.9830820880784674
COGS to revenue (%): 17.05217777249291
R&D to revenue (%): 16.222853026454604
SG&A to revenue (%): 45.695682893206815
Free cash flow (dilution-adjusted): 94407000
Buyback yield (%): 12.742645564012006
Retained earnings: -941494000
Receivables turnover: 5.481367236348478
Capitalized R&D asset: 229974830
ROCI (R&D-adjusted, %): 5.527510128314351
Rosenberg metric: 0.0431898197242842
FCF margin (%): 13.053361336985422
Revenue growth (%): 0.5683082296927492
Rule of 40 score: 13.62166956667817
Financial ratios for CARS — quarterly report dated 2025-12-31
Total revenue: 183903000
Gross profit: 152124000
Operating income: 21739000
Net income: 7398000
Capital expenditures: 385000
Operating cash flow: 37118000
Depreciation & amortization: 16466000
Net tangible assets: -221759000
Owner earnings: 23479000
Return on net tangible assets (%): -10.587619893668352
Capex to operating income (%): 1.7710106260637564
Buffett classification: The Great
Stock price: 12.2
P/E ratio: 34.012414193097946
Shares outstanding: 55903027
Book value: 472530000
P/B ratio: 1.4433304327767549
Market cap (USD): 682016929.4
Debt to equity: 0.9555287494973864
Current ratio: 1.8661045798901108
Quick ratio: 1.8661045798901108
Effective tax rate (%): 50.245477167260745
Interest coverage ratio: 2.9223013845947037
COGS to revenue (%): 17.28030537837882
R&D to revenue (%): 17.74739944427225
SG&A to revenue (%): 44.19775642594194
Free cash flow (dilution-adjusted): 22351000
Buyback yield (%): 3.309008769013117
Retained earnings: -941494000
Receivables turnover: 1.3937852893250975
Capitalized R&D asset: 60565820
ROCI (R&D-adjusted, %): 2.4524311265824577
Rosenberg metric: 0.022262509064539523
FCF margin (%): 12.153689716861606
Revenue growth (%): 1.283230436243274
Rule of 40 score: 13.43692015310488
Financial ratios for CELZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.1
Shares outstanding: 6487008
Market cap (USD): 143362876.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELZ — annual report dated 2022-12-31
Total revenue: 88600
Gross profit: 60109
Operating income: -10244372
Net income: -10144044
Capital expenditures: 0
Operating cash flow: -7796966
Depreciation & amortization: 92084
Net tangible assets: 15429079
Owner earnings: -10051960
Return on net tangible assets (%): -65.14944929635787
Buffett classification: The Gruesome
Stock price: 3.81
Shares outstanding: 6487008
Book value: 15864674
P/B ratio: 1.5578952634009373
Market cap (USD): 24715500.48
Debt to equity: 0
Current ratio: 5.644013882248953
Quick ratio: 5.640944927403593
COGS to revenue (%): 32.1568848758465
R&D to revenue (%): 7075.455981941309
SG&A to revenue (%): 4450.951467268623
Free cash flow (dilution-adjusted): -7865712
Buyback yield (%): 0
Retained earnings: -53811858
Inventory turnover: 2.7948793407886994
Capitalized R&D asset: 6268854
ROCI (R&D-adjusted, %): -27.40248188178586
FCF margin (%): -8877.778781038374
Rule of 40 score: -8877.778781038374
Financial ratios for CELZ — annual report dated 2023-12-31
Total revenue: 9000
Gross profit: 5400
Operating income: -5620132
Net income: -5286574
Capital expenditures: 100000
Operating cash flow: -8027885
Depreciation & amortization: 94584
Net tangible assets: 9902785
Owner earnings: -5291990
Return on net tangible assets (%): -53.439411236334024
Buffett classification: The Gruesome
Stock price: 4.61
Shares outstanding: 6487008
Book value: 10343796
P/B ratio: 2.891115300417758
Market cap (USD): 29905106.880000003
Debt to equity: 0
Current ratio: 27.654991733845996
Quick ratio: 27.63723700436733
COGS to revenue (%): 40
R&D to revenue (%): 21895.98888888889
SG&A to revenue (%): 39558.98888888889
Free cash flow (dilution-adjusted): -8164533
Buyback yield (%): 0.9060392296447796
Retained earnings: -59098432
Inventory turnover: 0.545950864422202
Capitalized R&D asset: 6170771.180000001
ROCI (R&D-adjusted, %): -38.72938719467346
Rosenberg metric: -0.008727113440510817
FCF margin (%): -90717.03333333334
Revenue growth (%): -89.84198645598194
Rule of 40 score: -90806.87531978932
Financial ratios for CELZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.1
Shares outstanding: 6487008
Market cap (USD): 20109724.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.31
Shares outstanding: 6487008
Market cap (USD): 14984988.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CELZ — annual report dated 2024-12-31
Total revenue: 11000
Gross profit: 6600
Operating income: -5743861
Net income: -5493481
Capital expenditures: 200000
Operating cash flow: -5301292
Depreciation & amortization: 110452
Net tangible assets: 5810940
Owner earnings: -5583029
Return on net tangible assets (%): -96.07789789603748
Buffett classification: The Gruesome
Stock price: 2.31
Shares outstanding: 6487008
Book value: 6341499
P/B ratio: 2.363004154065151
Market cap (USD): 14984988.48
Debt to equity: 0
Current ratio: 18.725516108947517
Quick ratio: 18.718819816630244
COGS to revenue (%): 40
R&D to revenue (%): 21825.245454545457
SG&A to revenue (%): 29447.563636363633
Free cash flow (dilution-adjusted): -5537940
Buyback yield (%): 1.1675951585382867
Retained earnings: -64591913
Inventory turnover: 2.0054694621695535
Capitalized R&D asset: 5789826.95
ROCI (R&D-adjusted, %): -56.79379727379814
Rosenberg metric: 0.0006089395368710352
FCF margin (%): -50344.90909090909
Revenue growth (%): 22.22222222222222
Rule of 40 score: -50322.68686868687
Financial ratios for CELZ — quarterly report dated 2025-03-31
Total revenue: 3000
Gross profit: 1800
Operating income: -1660478
Net income: -1638097
Capital expenditures: 0
Operating cash flow: -1591535
Depreciation & amortization: 30577
Net tangible assets: 7560905
Owner earnings: -1607520
Return on net tangible assets (%): -21.260946936907686
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 6487008
Book value: 8060887
P/B ratio: 1.7463099730836074
Market cap (USD): 14076807.36
Debt to equity: 0
Current ratio: 27.389549804984163
Quick ratio: 27.386078977048538
COGS to revenue (%): 40
R&D to revenue (%): 24776.8
SG&A to revenue (%): 29613.233333333334
Free cash flow (dilution-adjusted): -1595020
Buyback yield (%): 0.07103883532863804
Retained earnings: -66230010
Inventory turnover: 1.2072434607645874
Capitalized R&D asset: 743304
ROCI (R&D-adjusted, %): -13.231675687181252
FCF margin (%): -53167.33333333333
Rule of 40 score: -53167.33333333333
Financial ratios for CELZ — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -1263520
Net income: -1233303
Capital expenditures: 0
Operating cash flow: -1158747
Depreciation & amortization: 30742
Net tangible assets: 6358344
Owner earnings: -1202561
Return on net tangible assets (%): -18.913116371180923
Buffett classification: The Gruesome
Stock price: 2.65
Shares outstanding: 6487008
Book value: 6827584
P/B ratio: 2.517811747171474
Market cap (USD): 17190571.2
Debt to equity: 0
Current ratio: 23.889250262926627
Quick ratio: 23.885670138738817
Free cash flow (dilution-adjusted): -1158747
Buyback yield (%): 0
Retained earnings: -67463313
Inventory turnover: 0
Capitalized R&D asset: 999274.68
ROCI (R&D-adjusted, %): -15.039418087461879
Rosenberg metric: -0.002421620225372122
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CELZ — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -1273034
Net income: -1235934
Capital expenditures: 0
Operating cash flow: -1168609
Depreciation & amortization: 31059
Net tangible assets: 5153469
Owner earnings: -1204875
Return on net tangible assets (%): -23.379882560659627
Buffett classification: The Gruesome
Stock price: 3.33
Shares outstanding: 6487008
Book value: 5591650
P/B ratio: 3.8632132984002934
Market cap (USD): 21601736.64
Debt to equity: 0
Current ratio: 20.70586907362839
Quick ratio: 20.702065788416434
Free cash flow (dilution-adjusted): -1168609
Buyback yield (%): 0
Retained earnings: -68699247
Inventory turnover: 0
Capitalized R&D asset: 1046289.19
ROCI (R&D-adjusted, %): -20.75623614342471
Rosenberg metric: 0
Rule of 40 score: 0
Financial ratios for CELZ — annual report dated 2025-12-31
Total revenue: 6000
Gross profit: 3806
Operating income: -6142814
Net income: -5995008
Capital expenditures: 0
Operating cash flow: -5856445
Depreciation & amortization: 123327
Net tangible assets: 7107415
Owner earnings: -5871681
Return on net tangible assets (%): -82.61345369589365
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 6487008
Book value: 7524645
P/B ratio: 1.6897190073418746
Market cap (USD): 12714535.68
Debt to equity: 0
Current ratio: 25.972388374052233
Quick ratio: 25.972388374052233
COGS to revenue (%): 36.56666666666666
R&D to revenue (%): 37663.26666666667
SG&A to revenue (%): 62724.950000000004
Free cash flow (dilution-adjusted): -5859930
Buyback yield (%): 0.07865013911384926
Retained earnings: -70586921
Receivables turnover: 0.11519852545887413
Capitalized R&D asset: 4518627.46
ROCI (R&D-adjusted, %): -50.596065315622695
Rosenberg metric: -0.0011637898896898796
FCF margin (%): -97665.5
Revenue growth (%): -45.45454545454545
Rule of 40 score: -97710.95454545454
Financial ratios for CELZ — quarterly report dated 2025-12-31
Total revenue: 3000
Gross profit: 2006
Operating income: -1945782
Net income: -1887674
Capital expenditures: 0
Operating cash flow: -1937554
Depreciation & amortization: 30949
Net tangible assets: 7107415
Owner earnings: -1856725
Return on net tangible assets (%): -26.123773551987604
Buffett classification: The Gruesome
Stock price: 1.96
Shares outstanding: 6487008
Book value: 7524645
P/B ratio: 1.6897190073418746
Market cap (USD): 12714535.68
Debt to equity: 0
Current ratio: 25.972388374052233
Quick ratio: 25.972388374052233
COGS to revenue (%): 33.13333333333333
R&D to revenue (%): 18335.9
SG&A to revenue (%): 45558.73333333333
Free cash flow (dilution-adjusted): -1937554
Buyback yield (%): 0
Retained earnings: -70586921
Receivables turnover: 0.057599262729437065
Capitalized R&D asset: 1027146.3099999999
ROCI (R&D-adjusted, %): -22.23162685354787
Rosenberg metric: 0.004312550252174549
FCF margin (%): -64585.13333333333
Rule of 40 score: -64585.13333333333
Financial ratios for CEVA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 43.24
Shares outstanding: 27859369
Market cap (USD): 1204639115.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEVA — annual report dated 2022-12-31
Total revenue: 120583000
Gross profit: 105452000
Operating income: 7452000
Net income: -23183000
Capital expenditures: 3499000
Operating cash flow: 6924000
Depreciation & amortization: 7561000
Net tangible assets: 199685000
Owner earnings: -19121000
Return on net tangible assets (%): -9.57558154092696
Capex to operating income (%): 46.953837895866876
Buffett classification: The Good
Stock price: 25.58
Shares outstanding: 27859369
Book value: 258871000
P/B ratio: 2.752887187131815
Market cap (USD): 712642659.02
Debt to equity: 0.03046691209135052
Current ratio: 5.33761043331931
Quick ratio: 5.33761043331931
Effective tax rate (%): 430.66476054324517
Interest coverage ratio: 18.770780856423173
COGS to revenue (%): 12.54820331224136
R&D to revenue (%): 58.31419022581956
SG&A to revenue (%): 21.278289642818642
Free cash flow (dilution-adjusted): -11080000
Buyback yield (%): 0.9520900712469953
Retained earnings: 32160000
Receivables turnover: 4.042339926248743
Capitalized R&D asset: 70317000
ROCI (R&D-adjusted, %): 15.725900990213646
FCF margin (%): -9.188691606611215
Rule of 40 score: -9.188691606611215
Financial ratios for CEVA — annual report dated 2023-12-31
Total revenue: 97419000
Gross profit: 85771000
Operating income: -13467000
Net income: -11878000
Capital expenditures: 2884000
Operating cash flow: -6331000
Depreciation & amortization: 4883000
Net tangible assets: 203066000
Owner earnings: -9879000
Return on net tangible assets (%): -4.864920764677494
Buffett classification: The Gruesome
Stock price: 22.71
Shares outstanding: 27859369
Book value: 264341000
P/B ratio: 2.393447365297097
Market cap (USD): 632686269.99
Debt to equity: 0.02442299908073284
Current ratio: 7.78707181909473
Quick ratio: 7.78707181909473
COGS to revenue (%): 11.956599841919955
R&D to revenue (%): 74.61480819963252
SG&A to revenue (%): 26.642646711627094
Free cash flow (dilution-adjusted): -25413000
Buyback yield (%): 0.9741004811274646
Retained earnings: 20167000
Receivables turnover: 3.21440591282542
Capitalized R&D asset: 119801390
ROCI (R&D-adjusted, %): 2.9101640013435124
Rosenberg metric: -0.27988964261842797
FCF margin (%): -26.086287069257537
Revenue growth (%): -19.21000472703449
Rule of 40 score: -45.296291796292024
Financial ratios for CEVA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.15
Shares outstanding: 27859369
Market cap (USD): 672803761.3499999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEVA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 31.55
Shares outstanding: 27859369
Market cap (USD): 878963091.95
Buyback yield (%): 0.1137704198456703
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEVA — annual report dated 2024-12-31
Total revenue: 106939000
Gross profit: 94171000
Operating income: -7545000
Net income: -8786000
Capital expenditures: 2955000
Operating cash flow: 3471000
Depreciation & amortization: 4136000
Net tangible assets: 206371000
Owner earnings: -7605000
Return on net tangible assets (%): -3.6851107956059717
Buffett classification: The Gruesome
Stock price: 31.55
Shares outstanding: 27859369
Book value: 266556000
P/B ratio: 3.2974800490328486
Market cap (USD): 878963091.95
Debt to equity: 0.0208624078992782
Current ratio: 7.086409643289986
Quick ratio: 7.086409643289986
COGS to revenue (%): 11.939516920861426
R&D to revenue (%): 66.96901972152348
SG&A to revenue (%): 27.58675506597219
Free cash flow (dilution-adjusted): -15059000
Buyback yield (%): 0.9620426702149879
Retained earnings: 11193000
Receivables turnover: 2.8740089763229326
Capitalized R&D asset: 143522240
ROCI (R&D-adjusted, %): -1.7703096920952006
Rosenberg metric: 0.11556081387830346
FCF margin (%): -14.081859751821133
Revenue growth (%): 9.772221024646116
Rule of 40 score: -4.309638727175017
Financial ratios for CEVA — quarterly report dated 2025-03-31
Total revenue: 24245000
Gross profit: 20758000
Operating income: -4382000
Net income: -3327000
Capital expenditures: 311000
Operating cash flow: -7404000
Depreciation & amortization: 859000
Net tangible assets: 209155000
Owner earnings: -2779000
Return on net tangible assets (%): -1.3286796873132367
Buffett classification: The Gruesome
Stock price: 25.61
Shares outstanding: 27859369
Book value: 269132000
P/B ratio: 2.6510353287234514
Market cap (USD): 713478440.09
Debt to equity: 0.01795401513012202
Current ratio: 7.449105702221154
Quick ratio: 7.449105702221154
COGS to revenue (%): 14.382346875644464
R&D to revenue (%): 72.62940812538668
SG&A to revenue (%): 30.447514951536398
Free cash flow (dilution-adjusted): -12038000
Buyback yield (%): 0
Retained earnings: 7359000
Receivables turnover: 0.5939635953845023
Capitalized R&D asset: 17609000
ROCI (R&D-adjusted, %): 2.4650077673654502
FCF margin (%): -49.651474530831095
Rule of 40 score: -49.651474530831095
Financial ratios for CEVA — quarterly report dated 2025-06-30
Total revenue: 25678000
Gross profit: 22129000
Operating income: -4482000
Net income: -3704000
Capital expenditures: 691000
Operating cash flow: 1183000
Depreciation & amortization: 1106000
Net tangible assets: 206124000
Owner earnings: -3289000
Return on net tangible assets (%): -1.59564145853952
Buffett classification: The Gruesome
Stock price: 21.98
Shares outstanding: 27859369
Book value: 265892000
P/B ratio: 2.302998701051555
Market cap (USD): 612348930.62
Debt to equity: 0.016416439757495526
Current ratio: 8.578095472845288
Quick ratio: 8.578095472845288
COGS to revenue (%): 13.821169873043072
R&D to revenue (%): 73.05086065892982
SG&A to revenue (%): 29.998442246280867
Free cash flow (dilution-adjusted): -4410000
Buyback yield (%): 1.0062890113584437
Retained earnings: 3655000
Receivables turnover: 0.6999972739416078
Capitalized R&D asset: 30556030
ROCI (R&D-adjusted, %): 0.6968531455822642
Rosenberg metric: 0.07785791356692601
FCF margin (%): -17.17423475348547
Revenue growth (%): 5.91049700969272
Rule of 40 score: -11.263737743792753
Financial ratios for CEVA — quarterly report dated 2025-09-30
Total revenue: 28384000
Gross profit: 24992000
Operating income: -2084000
Net income: -2509000
Capital expenditures: 426000
Operating cash flow: -5859000
Depreciation & amortization: 1155000
Net tangible assets: 209159000
Owner earnings: -1780000
Return on net tangible assets (%): -0.8510272089654282
Buffett classification: The Gruesome
Stock price: 26.41
Shares outstanding: 27859369
Book value: 268719000
P/B ratio: 2.7380495435380454
Market cap (USD): 735765935.29
Debt to equity: 0.01405929614206662
Current ratio: 8.677594301440829
Quick ratio: 8.677594301440829
COGS to revenue (%): 11.950394588500563
R&D to revenue (%): 68.81341600901916
SG&A to revenue (%): 26.053410372040588
Free cash flow (dilution-adjusted): -11158000
Buyback yield (%): 0.13428183510705516
Retained earnings: 1103000
Receivables turnover: 0.5711181311495201
Capitalized R&D asset: 37910830
ROCI (R&D-adjusted, %): -0.37122102866568785
Rosenberg metric: 0.15262821196289583
FCF margin (%): -39.3108793686584
Revenue growth (%): 10.538203909961835
Rule of 40 score: -28.77267545869656
Financial ratios for CEVA — quarterly report dated 2025-12-31
Total revenue: 31291000
Gross profit: 27561000
Operating income: -398000
Net income: -1098000
Capital expenditures: 1493000
Operating cash flow: 8724000
Depreciation & amortization: 1149000
Net tangible assets: 277106000
Owner earnings: -1442000
Return on net tangible assets (%): -0.520378483324071
Buffett classification: The Gruesome
Stock price: 21.52
Shares outstanding: 27859369
Book value: 336458000
P/B ratio: 1.7818973568171956
Market cap (USD): 599533620.88
Debt to equity: 0.047943576910045235
Current ratio: 9.930481469860196
Quick ratio: 9.930481469860196
Effective tax rate (%): 204.27350427350427
COGS to revenue (%): 11.920360487041002
R&D to revenue (%): 60.50941165191269
SG&A to revenue (%): 28.362788022114987
Free cash flow (dilution-adjusted): 1533000
Buyback yield (%): 0
Retained earnings: -24000
Receivables turnover: 0.6339985817039814
Capitalized R&D asset: 38210580
ROCI (R&D-adjusted, %): -0.13541701914057586
Rosenberg metric: 0.13152774933442557
FCF margin (%): 4.8991722859608196
Revenue growth (%): 10.241685456595265
Rule of 40 score: 15.140857742556085
Financial ratios for CEVA — annual report dated 2025-12-31
Total revenue: 109598000
Gross profit: 95440000
Operating income: -11346000
Net income: -10638000
Capital expenditures: 2921000
Operating cash flow: -3356000
Depreciation & amortization: 4269000
Net tangible assets: 277106000
Owner earnings: -9290000
Return on net tangible assets (%): -3.3525077046328846
Buffett classification: The Gruesome
Stock price: 21.52
Shares outstanding: 27859369
Book value: 336458000
P/B ratio: 1.7818973568171956
Market cap (USD): 599533620.88
Debt to equity: 0.047943576910045235
Current ratio: 9.930481469860196
Quick ratio: 9.930481469860196
COGS to revenue (%): 12.918118943776346
R&D to revenue (%): 68.27953064836949
SG&A to revenue (%): 28.60909870618077
Free cash flow (dilution-adjusted): -26073000
Buyback yield (%): 1.1925936679756468
Retained earnings: -24000
Receivables turnover: 2.2206058150136765
Capitalized R&D asset: 146803090
ROCI (R&D-adjusted, %): -1.8877273609028422
Rosenberg metric: 0.017719504021447723
FCF margin (%): -23.78966769466596
Revenue growth (%): 2.486464245972003
Rule of 40 score: -21.30320344869396
Financial ratios for CHR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 590
Shares outstanding: 1845453
Market cap (USD): 1088817270
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHR — annual report dated 2022-12-31
Total revenue: 22568821.83908046
Gross profit: 16738362.068965517
Operating income: 3839942.528735632
Net income: 3863505.747126437
Capital expenditures: 3591.9540229885056
Operating cash flow: 1111925.287356322
Depreciation & amortization: 479597.7011494253
Net tangible assets: 21857902.298850574
Owner earnings: 4339511.494252874
Return on net tangible assets (%): 19.853284340469727
Capex to operating income (%): 0.09354186934071691
Buffett classification: The Great
Stock price: 730
P/E ratio: 348.693849103756
Shares outstanding: 1845453
Book value: 24784913.79310345
P/B ratio: 54.35486688579329
Market cap (USD): 1347180690
Debt to equity: 0.02956470322255265
Current ratio: 5.587484423912714
Quick ratio: 5.587484423912714
Effective tax rate (%): 1.538003202621681
Interest coverage ratio: 287.3763440860215
COGS to revenue (%): 25.834134416440136
R&D to revenue (%): 0.8473443299231597
SG&A to revenue (%): 56.304152687501194
Free cash flow (dilution-adjusted): -92097.7011494253
Buyback yield (%): 0
Retained earnings: 21650143.67816092
Receivables turnover: 1.6022910418834282
Capitalized R&D asset: 191235.63218390805
ROCI (R&D-adjusted, %): 15.834150462657668
FCF margin (%): -0.408074917716563
Rule of 40 score: -0.408074917716563
Financial ratios for CHR — annual report dated 2023-12-31
Total revenue: 21424331.92686357
Gross profit: 15861884.669479605
Operating income: 4118846.6947960616
Net income: 4293670.886075949
Capital expenditures: 421.94092827004215
Operating cash flow: 5931645.569620253
Depreciation & amortization: 531504.9226441631
Net tangible assets: 36522362.86919831
Owner earnings: 4824753.867791843
Return on net tangible assets (%): 13.210409975584774
Capex to operating income (%): 0.010244152296397472
Buffett classification: The Great
Stock price: 157
P/E ratio: 67.47981591686322
Shares outstanding: 1845453
Book value: 39382137.834036574
P/B ratio: 7.357044003578481
Market cap (USD): 289736121
Debt to equity: 0.0212637541204327
Current ratio: 6.6398511370275
Quick ratio: 6.6398511370275
Effective tax rate (%): 0.19941809147079018
COGS to revenue (%): 25.963223853945788
R&D to revenue (%): 1.0733487825533228
SG&A to revenue (%): 53.73833923073389
Free cash flow (dilution-adjusted): 5931223.6286919825
Buyback yield (%): 0
Retained earnings: 25479887.482419126
Receivables turnover: 1.8766416163607245
Capitalized R&D asset: 358085.67947039136
ROCI (R&D-adjusted, %): 10.537282476026318
Rosenberg metric: -4.583232682510856
FCF margin (%): 27.684520800645977
Revenue growth (%): -5.071110580682051
Rule of 40 score: 22.613410219963924
Financial ratios for CHR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 36227671.23287671
Buffett classification: The Gruesome
Stock price: 124.5
Shares outstanding: 1845453
Book value: 41790410.95890411
P/B ratio: 5.497885596912185
Market cap (USD): 229758898.5
Debt to equity: 0.037102959976398855
Current ratio: 7.658153930979173
Quick ratio: 7.658153930979173
Buyback yield (%): 0
Retained earnings: 28373698.630136985
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHR — annual report dated 2024-12-31
Total revenue: 20163835.616438355
Gross profit: 14768219.178082192
Operating income: 3505753.4246575343
Net income: 3557260.273972603
Capital expenditures: 136.986301369863
Operating cash flow: 3133561.6438356163
Depreciation & amortization: 523561.6438356165
Net tangible assets: 36227671.23287671
Owner earnings: 4080684.9315068494
Return on net tangible assets (%): 11.264000121000372
Capex to operating income (%): 0.003907471084713973
Buffett classification: The Great
Stock price: 124.5
P/E ratio: 64.58872300716266
Shares outstanding: 1845453
Book value: 41790410.95890411
P/B ratio: 5.497885596912185
Market cap (USD): 229758898.5
Debt to equity: 0.037102959976398855
Current ratio: 7.658153930979173
Quick ratio: 7.658153930979173
Effective tax rate (%): -0.1311020282254955
COGS to revenue (%): 26.75887931737276
R&D to revenue (%): 2.3288676322726163
SG&A to revenue (%): 53.52591103019104
Free cash flow (dilution-adjusted): -511232.87671232875
Buyback yield (%): 0
Retained earnings: 28373698.630136985
Receivables turnover: 1.909800970495887
Capitalized R&D asset: 686768.5296743859
ROCI (R&D-adjusted, %): 8.614737091800235
Rosenberg metric: -4.755939843324528
FCF margin (%): -2.535394983559336
Revenue growth (%): -5.883480123105737
Rule of 40 score: -8.418875106665073
Financial ratios for CHR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 39515620.64156207
Buffett classification: The Gruesome
Stock price: 73
Shares outstanding: 1845453
Book value: 44935983.26359832
P/B ratio: 2.9979998036257998
Market cap (USD): 134718069
Debt to equity: 0.02886796962050461
Current ratio: 8.286921776548333
Quick ratio: 8.286921776548333
Buyback yield (%): 0
Retained earnings: 30447977.684797768
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIFL.NS — quarterly report dated 2025-06-30
Total revenue: 15633653.171074187
Gross profit: 1797601.2169435995
Operating income: -1204060.3791247369
Net income: -333337.23379358766
Capital expenditures: 0
Depreciation & amortization: 961572.6655745378
Owner earnings: 628235.4317809502
Buffett classification: The Gruesome
Stock price: 0.47437397612918325
Shares outstanding: 391056300
Market cap (USD): 185506931.92136672
COGS to revenue (%): 88.5017199929344
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.863148996402801
Rule of 40 score: 11.863148996402801
Financial ratios for CIFL.NS — quarterly report dated 2025-09-30
Total revenue: 14384114.994363021
Gross profit: 1473472.3788049605
Operating income: -1104216.459977452
Net income: 5053145.434047351
Capital expenditures: 0
Depreciation & amortization: 915242.3900789177
Net tangible assets: 69614103.72040586
Owner earnings: 5968387.824126269
Return on net tangible assets (%): 8.573532524526012
Buffett classification: The Gruesome
Stock price: 0.3896279594137542
P/E ratio: 32.76200803460169
Shares outstanding: 391056300
Book value: 78246437.42953777
P/B ratio: 1.9472639674119534
Market cap (USD): 152366468.1848929
Debt to equity: 1.0082801440077664
Current ratio: 65.667202169831
Quick ratio: 65.62477571458376
Effective tax rate (%): 12.190194120145563
COGS to revenue (%): 89.75625278731157
Buyback yield (%): 0
Inventory turnover: 140.78854192279323
Receivables turnover: 13.103596664201792
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6193193961597947
Revenue growth (%): -7.992617995537319
Rule of 40 score: -7.992617995537319
Financial ratios for CIFL.NS — quarterly report dated 2025-12-31
Total revenue: 15831469.310460065
Gross profit: 2554104.9348334633
Operating income: -972139.9131112845
Net income: -325799.26478779106
Capital expenditures: 0
Depreciation & amortization: 853080.093572463
Owner earnings: 527280.828784672
Buffett classification: The Gruesome
Stock price: 0.3917789907541495
P/E ratio: 35.42449606590959
Shares outstanding: 391056300
Market cap (USD): 153207642.5420519
COGS to revenue (%): 83.86691162553099
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 10.062171476411624
Rule of 40 score: 10.062171476411624
Financial ratios for CITI.TO — quarterly report dated 2025-12-31
Total revenue: 14357664233.576641
Net income: 1840875912.4087589
Capital expenditures: 27737226.27737226
Operating cash flow: 19383211678.832115
Depreciation & amortization: 805109489.0510948
Net tangible assets: 137889781021.8978
Owner earnings: 2618248175.1824813
Return on net tangible assets (%): 1.898797833877687
Buffett classification: The Gruesome
Stock price: 34.97810218978102
P/E ratio: 18.122959952093918
Shares outstanding: 5379836192
Book value: 156074452554.7444
P/B ratio: 1.2056839348647017
Market cap (USD): 188176460088.05838
Debt to equity: 1.7196780499667963
Effective tax rate (%): 33.79690369981632
COGS to revenue (%): 0
SG&A to revenue (%): 37.671581087951196
Free cash flow (dilution-adjusted): 18192700729.927006
Buyback yield (%): 2.327369768644907
Retained earnings: 157027737226.27737
Receivables turnover: 0.31322653587693877
Capitalized R&D asset: 0
FCF margin (%): 126.7107269954245
Revenue growth (%): -9.6757036222153
Rule of 40 score: 117.0350233732092
Financial ratios for CITI.TO — annual report dated 2025-12-31
Total revenue: 62199270072.9927
Net income: 10548905109.48905
Capital expenditures: 45255474.45255474
Operating cash flow: -49366423357.66423
Depreciation & amortization: 3191970802.919708
Net tangible assets: 137889781021.8978
Owner earnings: 13695620437.956203
Return on net tangible assets (%): 9.93229544383804
Buffett classification: The Gruesome
Stock price: 34.97810218978102
P/E ratio: 17.838482585153614
Shares outstanding: 5379836192
Book value: 156074452554.7444
P/B ratio: 1.2056839348647017
Market cap (USD): 188176460088.05838
Debt to equity: 1.7196780499667963
Effective tax rate (%): 27.098043171272952
COGS to revenue (%): 0
SG&A to revenue (%): 36.17171088918358
Free cash flow (dilution-adjusted): -54125547445.25547
Buyback yield (%): 7.079083046294925
Retained earnings: 157027737226.27737
Receivables turnover: 1.3569381190483776
Capitalized R&D asset: 0
FCF margin (%): -87.0195862133712
Revenue growth (%): 10.255052811854865
Rule of 40 score: -76.76453340151633
Financial ratios for CPSH — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.79
Shares outstanding: 19268448
Market cap (USD): 73027417.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPSH — annual report dated 2022-12-31
Total revenue: 26586926
Gross profit: 7301080
Operating income: 2234420
Net income: 2131400
Capital expenditures: 436372
Operating cash flow: 3551399
Depreciation & amortization: 445739
Net tangible assets: 15705516
Owner earnings: 2140767
Return on net tangible assets (%): 13.630669632248951
Capex to operating income (%): 19.529542342084298
Buffett classification: The Great
Stock price: 2.69
P/E ratio: 24.318347152106597
Shares outstanding: 19268448
Book value: 15705516
P/B ratio: 3.3002497415557692
Market cap (USD): 51832125.12
Debt to equity: 0.03594647893135125
Current ratio: 3.3120810995694816
Quick ratio: 2.4057056710957774
Effective tax rate (%): 26.189575809961536
COGS to revenue (%): 72.53883356052519
SG&A to revenue (%): 19.056960552716777
Free cash flow (dilution-adjusted): 2861268
Buyback yield (%): 0
Retained earnings: -24125092
Inventory turnover: 3.955339946401701
Receivables turnover: 5.95632894476552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.707776068819976
FCF margin (%): 10.761936148616805
Rule of 40 score: 10.761936148616805
Financial ratios for CPSH — annual report dated 2023-12-31
Total revenue: 27550646
Gross profit: 6825409
Operating income: 1699363
Net income: 1370296
Capital expenditures: 718274
Operating cash flow: 1267453
Depreciation & amortization: 489103
Net tangible assets: 17321974
Owner earnings: 1141125
Return on net tangible assets (%): 6.587730705518897
Capex to operating income (%): 42.2672495517438
Buffett classification: The Good
Stock price: 2.35
P/E ratio: 33.0445778138446
Shares outstanding: 19268448
Book value: 17321974
P/B ratio: 2.6140700130366206
Market cap (USD): 45280852.800000004
Debt to equity: 0.022335041029388453
Current ratio: 4.4593891281774
Quick ratio: 3.333268858563081
Effective tax rate (%): 29.814109028924168
COGS to revenue (%): 75.22595658918488
SG&A to revenue (%): 18.605901291751927
Free cash flow (dilution-adjusted): 344382
Buyback yield (%): 0
Retained earnings: -22754796
Inventory turnover: 4.523254829296825
Receivables turnover: 6.1602223978198465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.692180172620837
FCF margin (%): 1.2499960980951228
Revenue growth (%): 3.624789116274668
Rule of 40 score: 4.8747852143697905
Financial ratios for CPSH — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.42
Shares outstanding: 19268448
Market cap (USD): 27361196.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPSH — annual report dated 2024-12-31
Total revenue: 21123346
Gross profit: -118638
Operating income: -4380928
Net income: -3135449
Capital expenditures: 994261
Operating cash flow: -3476421
Depreciation & amortization: 547152
Net tangible assets: 14512119
Owner earnings: -3582558
Return on net tangible assets (%): -24.68666360853298
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 19268448
Book value: 14512119
P/B ratio: 2.13767550279873
Market cap (USD): 31022201.28
Debt to equity: 0.013377095378007856
Current ratio: 3.287023017724693
Quick ratio: 2.2815637659458394
COGS to revenue (%): 100.56164397439686
SG&A to revenue (%): 20.17810057175601
Free cash flow (dilution-adjusted): -4780776
Buyback yield (%): 0
Retained earnings: -25890245
Inventory turnover: 4.904562525715378
Receivables turnover: 4.1950721271286815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.069386541487376
FCF margin (%): -22.632664351566273
Revenue growth (%): -23.329035551471282
Rule of 40 score: -45.961699903037555
Financial ratios for CPSH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 19268448
Market cap (USD): 31022201.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPSH — quarterly report dated 2025-03-31
Total revenue: 7505921
Gross profit: 1231001
Operating income: 129651
Net income: 95962
Capital expenditures: 93070
Operating cash flow: -1252723
Depreciation & amortization: 164738
Net tangible assets: 14716067
Owner earnings: 167630
Return on net tangible assets (%): 1.1390951128450284
Capex to operating income (%): 71.78502286908702
Buffett classification: The Good
Stock price: 1.59
P/E ratio: 79.81501094183115
Shares outstanding: 19268448
Book value: 14716067
P/B ratio: 2.081862791192783
Market cap (USD): 30636832.32
Debt to equity: 0.00998908200132549
Current ratio: 3.2915262450566662
Quick ratio: 2.2127939888344086
Effective tax rate (%): 46.72536599177247
COGS to revenue (%): 83.59960090174144
SG&A to revenue (%): 14.673082756932827
Free cash flow (dilution-adjusted): -1467979
Buyback yield (%): 0
Retained earnings: -25794283
Inventory turnover: 1.3037892650752685
Receivables turnover: 1.152430054697246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8791481367763578
FCF margin (%): -19.55761324959322
Rule of 40 score: -19.55761324959322
Financial ratios for CPSH — quarterly report dated 2025-06-30
Total revenue: 8078657
Gross profit: 1336316
Operating income: 136927
Net income: 103833
Capital expenditures: 172848
Operating cash flow: 649256
Depreciation & amortization: 156451
Net tangible assets: 14856060
Owner earnings: 87436
Return on net tangible assets (%): 0.5885544350251682
Capex to operating income (%): 126.23368656291309
Buffett classification: The Gruesome
Stock price: 2.77
P/E ratio: 267.1418251708001
Shares outstanding: 19268448
Book value: 14877423
P/B ratio: 3.587556861158011
Market cap (USD): 53373600.96
Debt to equity: 0.007259321725274599
Current ratio: 3.3399108285680343
Quick ratio: 2.174664374242054
Effective tax rate (%): 33.419898430286246
COGS to revenue (%): 83.45868626431349
SG&A to revenue (%): 14.846390928591225
Free cash flow (dilution-adjusted): 405691
Buyback yield (%): 0
Retained earnings: -25690450
Inventory turnover: 1.2970415405504088
Receivables turnover: 1.342252321585344
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9184368858451777
FCF margin (%): 5.021762899452224
Revenue growth (%): 7.630456009329169
Rule of 40 score: 12.652218908781393
Financial ratios for CPSH — quarterly report dated 2025-09-30
Total revenue: 8803695
Gross profit: 1502566
Operating income: 276082
Net income: 207964
Capital expenditures: 173574
Operating cash flow: 1050382
Depreciation & amortization: 137289
Net tangible assets: 15108702
Owner earnings: 171679
Return on net tangible assets (%): 1.136292184464291
Capex to operating income (%): 62.8704515325157
Buffett classification: The Good
Stock price: 3.57
P/E ratio: 168.6985679286049
Shares outstanding: 19268448
Book value: 15132448
P/B ratio: 4.54575223784017
Market cap (USD): 68788359.36
Debt to equity: 0.02445076963092819
Current ratio: 3.1157582870765075
Quick ratio: 2.0525415136374936
Effective tax rate (%): 35.32753875577255
COGS to revenue (%): 82.93255275199787
SG&A to revenue (%): 13.931468548149384
Free cash flow (dilution-adjusted): 822912
Buyback yield (%): 0
Retained earnings: -25482486
Inventory turnover: 1.3561595414289112
Receivables turnover: 1.5239922849112613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.795921022460234
FCF margin (%): 9.347347903351945
Revenue growth (%): 8.974734290612908
Rule of 40 score: 18.322082193964853
Financial ratios for CPSH — annual report dated 2025-12-31
Total revenue: 32596314
Gross profit: 5289359
Operating income: 443974
Net income: 420354
Capital expenditures: 730662
Operating cash flow: 243644
Depreciation & amortization: 601191
Net tangible assets: 24613496
Owner earnings: 290883
Return on net tangible assets (%): 1.181802861324535
Capex to operating income (%): 164.5731506799948
Buffett classification: The Gruesome
Stock price: 3.09
P/E ratio: 141.64134115531195
Shares outstanding: 19268448
Book value: 24635274
P/B ratio: 2.416839541545184
Market cap (USD): 59539504.32
Debt to equity: 0.013638979619224044
Current ratio: 5.298450265425041
Quick ratio: 4.099952538830066
Effective tax rate (%): 38.42212124141932
COGS to revenue (%): 83.77313766212953
SG&A to revenue (%): 14.86482490014055
Free cash flow (dilution-adjusted): -786159
Buyback yield (%): 0
Retained earnings: -25469891
Inventory turnover: 4.877629475670489
Receivables turnover: 5.803923432963781
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.787295297918311
FCF margin (%): -2.4118033713873293
Revenue growth (%): 54.31416026608663
Rule of 40 score: 51.9023568946993
Financial ratios for CPSH — quarterly report dated 2025-12-31
Total revenue: 8208042
Gross profit: 1219477
Operating income: -98685
Net income: 12595
Capital expenditures: 291170
Operating cash flow: -203271
Depreciation & amortization: 142713
Net tangible assets: 24613496
Owner earnings: -135862
Return on net tangible assets (%): -0.5519817257979118
Buffett classification: The Gruesome
Stock price: 3.09
P/E ratio: 141.64134115531195
Shares outstanding: 19268448
Book value: 24635274
P/B ratio: 2.416839541545184
Market cap (USD): 59539504.32
Debt to equity: 0.013638979619224044
Current ratio: 5.298450265425041
Quick ratio: 4.099952538830066
Effective tax rate (%): 49.60790589741538
COGS to revenue (%): 85.14290009724608
SG&A to revenue (%): 16.059396382230986
Free cash flow (dilution-adjusted): -546783
Buyback yield (%): 0
Retained earnings: -25469891
Inventory turnover: 1.248313136218928
Receivables turnover: 1.4614795802541016
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.397273796382375
FCF margin (%): -6.6615521704201806
Revenue growth (%): -6.76594316363754
Rule of 40 score: -13.42749533405772
Financial ratios for DDS — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 205.63
Shares outstanding: 11630836
Market cap (USD): 2391648806.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DDS — annual report dated 2023-01-31
Total revenue: 6996215000
Gross profit: 3012617000
Operating income: 1126691000
Net income: 891637000
Capital expenditures: 120105000
Operating cash flow: 948391000
Depreciation & amortization: 190030000
Net tangible assets: 1598638000
Owner earnings: 961562000
Return on net tangible assets (%): 60.14882668871877
Capex to operating income (%): 10.659976870322032
Buffett classification: The Great
Stock price: 335.08
P/E ratio: 4.370904893897404
Shares outstanding: 11630836
Book value: 1598638000
P/B ratio: 2.4378630602300206
Market cap (USD): 3897260526.8799996
Debt to equity: 0.347308146059333
Current ratio: 2.4120373334761416
Quick ratio: 1.1078943048636667
Effective tax rate (%): 19.633752062927513
Interest coverage ratio: 25.9881671818056
COGS to revenue (%): 56.93933076670743
SG&A to revenue (%): 24.262919307082473
Free cash flow (dilution-adjusted): 828286000
Buyback yield (%): 11.619777453331741
Retained earnings: 5648700000
Inventory turnover: 3.556123505634668
Receivables turnover: 122.84406166596432
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 45.61153012988075
FCF margin (%): 11.839058691020787
Rule of 40 score: 11.839058691020787
Financial ratios for DDS — annual report dated 2024-01-31
Total revenue: 6874420000
Gross profit: 2843312000
Operating income: 924755000
Net income: 738847000
Capital expenditures: 132944000
Operating cash flow: 883590000
Depreciation & amortization: 181182000
Net tangible assets: 1697068000
Owner earnings: 787085000
Return on net tangible assets (%): 46.379107967388464
Capex to operating income (%): 14.376132056598776
Buffett classification: The Great
Stock price: 348.85
P/E ratio: 5.491552565822153
Shares outstanding: 11630836
Book value: 1697068000
P/B ratio: 2.390839458760639
Market cap (USD): 4057417138.6000004
Debt to equity: 0.3325977509445703
Current ratio: 2.6677064255650214
Quick ratio: 1.346062124587439
Effective tax rate (%): 19.394141718951317
Interest coverage ratio: 22.754798228346456
COGS to revenue (%): 58.63924520177702
SG&A to revenue (%): 25.296446827514174
Free cash flow (dilution-adjusted): 750646000
Buyback yield (%): 6.935717733402684
Retained earnings: 6048288000
Inventory turnover: 3.68474559848775
Receivables turnover: 113.53857333971956
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.280506647845414
FCF margin (%): 10.919408473733057
Revenue growth (%): -1.7408698846447686
Rule of 40 score: 9.178538589088289
Financial ratios for DDS — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 335.25
Shares outstanding: 11630836
Market cap (USD): 3899237769
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DDS — quarterly report dated 2025-01-31
Total revenue: 2051616000
Gross profit: 739536000
Operating income: 239656000
Net income: 214359000
Capital expenditures: 15405000
Operating cash flow: 364693000
Depreciation & amortization: 41705000
Net tangible assets: 1796160000
Owner earnings: 240659000
Return on net tangible assets (%): 13.398527970782112
Capex to operating income (%): 6.427963414227059
Buffett classification: The Great
Stock price: 447.32
P/E ratio: 6.0677479829631595
Shares outstanding: 11630836
Book value: 1796160000
P/B ratio: 2.8965713296810978
Market cap (USD): 5202705559.5199995
Debt to equity: 0.309172345448067
Current ratio: 2.836331275616656
Quick ratio: 1.4325241404421576
Effective tax rate (%): 8.889635063797954
COGS to revenue (%): 63.95348837209303
SG&A to revenue (%): 22.35082003649806
Free cash flow (dilution-adjusted): 349288000
Buyback yield (%): 0.3082819086436972
Retained earnings: 6228048000
Inventory turnover: 1.1194772905864696
Receivables turnover: 36.83332136445242
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.888829544965631
FCF margin (%): 17.02501832701636
Rule of 40 score: 17.02501832701636
Financial ratios for DDS — annual report dated 2025-01-31
Total revenue: 6590231000
Gross profit: 2670682000
Operating income: 740162000
Net income: 593476000
Capital expenditures: 104552000
Operating cash flow: 714127000
Depreciation & amortization: 179522000
Net tangible assets: 1796160000
Owner earnings: 668446000
Return on net tangible assets (%): 37.21528148939961
Capex to operating income (%): 14.12555629713495
Buffett classification: The Great
Stock price: 447.32
P/E ratio: 8.766496976322548
Shares outstanding: 11630836
Book value: 1796160000
P/B ratio: 2.8965713296810978
Market cap (USD): 5202705559.5199995
Debt to equity: 0.309172345448067
Current ratio: 2.836331275616656
Quick ratio: 1.4325241404421576
Effective tax rate (%): 18.668605360277706
Interest coverage ratio: 18.56252194412399
COGS to revenue (%): 59.475138276640074
SG&A to revenue (%): 26.59471268913032
Free cash flow (dilution-adjusted): 609575000
Buyback yield (%): 2.3263665147940173
Retained earnings: 6228048000
Inventory turnover: 3.3441909752765886
Receivables turnover: 118.31653500897666
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.45257307833249
FCF margin (%): 9.249675770090608
Revenue growth (%): -4.134006941676534
Rule of 40 score: 5.115668828414074
Financial ratios for DDS — quarterly report dated 2025-04-30
Total revenue: 1546971000
Gross profit: 689280000
Operating income: 218509000
Net income: 163817000
Capital expenditures: 16853000
Operating cash flow: 232632000
Depreciation & amortization: 44853000
Net tangible assets: 1857885000
Owner earnings: 191817000
Return on net tangible assets (%): 10.324481870514052
Capex to operating income (%): 7.712725791614991
Buffett classification: The Great
Stock price: 331.49
P/E ratio: 5.88386099373081
Shares outstanding: 11630836
Book value: 1857885000
P/B ratio: 2.075212311655458
Market cap (USD): 3855505825.6400003
Debt to equity: 0.29815838978192943
Current ratio: 2.413826600684528
Quick ratio: 1.132596193673563
Effective tax rate (%): 23.34146010472772
COGS to revenue (%): 55.44325006738976
SG&A to revenue (%): 27.556172675505874
Free cash flow (dilution-adjusted): 215779000
Buyback yield (%): 2.5418454654709848
Retained earnings: 6387941000
Inventory turnover: 0.5837479913672179
Receivables turnover: 27.170826380960744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.916278567621979
FCF margin (%): 13.948483843588535
Revenue growth (%): -24.597439286884097
Rule of 40 score: -10.648955443295561